Significant Progress in Predicting the Crystal Structures of Small Organic Molecules - A Report on the Fourth Blind Test

The Pfizer Institute for Pharmaceutical Materials Science, University Chemical Laboratory, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, England.
Acta crystallographica. Section B, Structural science (Impact Factor: 2.18). 05/2009; 65(Pt 2):107-25. DOI: 10.1107/S0108768109004066
Source: PubMed


We report on the organization and outcome of the fourth blind test of crystal structure prediction, an international collaborative project organized to evaluate the present state in computational methods of predicting the crystal structures of small organic molecules. There were 14 research groups which took part, using a variety of methods to generate and rank the most likely crystal structures for four target systems: three single-component crystal structures and a 1:1 cocrystal. Participants were challenged to predict the crystal structures of the four systems, given only their molecular diagrams, while the recently determined but as-yet unpublished crystal structures were withheld by an independent referee. Three predictions were allowed for each system. The results demonstrate a dramatic improvement in rates of success over previous blind tests; in total, there were 13 successful predictions and, for each of the four targets, at least two groups correctly predicted the observed crystal structure. The successes include one participating group who correctly predicted all four crystal structures as their first ranked choice, albeit at a considerable computational expense. The results reflect important improvements in modelling methods and suggest that, at least for the small and fairly rigid types of molecules included in this blind test, such calculations can be constructively applied to help understand crystallization and polymorphism of organic molecules.

Download full-text


Available from: Graeme Day,
  • Source
    • "It was believed that the reason for the failure was the kinetic nature of crystallization. But it turned out that successful CSP for small drug molecules is possible [96] [97]. Only recently, the structures of three known polymorphs of sulphanilamide have been correctly predicted from ab initio [98]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The process of drug development proceeds through several stages including discovery, product characterisation, formulation, delivery and packaging development, pharmacokinetics and drug disposition, preclinical toxicology testing and IND (Investigational New Drug) application; bioanalytical testing and clinical trials. With the development of experimental (e.g. XRD, NMR, NQR) and theoretical methods (e.g. ab initio, DFT at different levels) not only the number of recognised 3D structures of ligands and targets has dramatically increased, but also the amount of information on structural dynamics and electronic properties of drugs. The increased availability of these data is crucial for rational drug design, which in general has to involve many different pathways to achieve one common goal that is a drug more efficient and selective to its therapeutic target which exhibits efficacy in vivo and shows low toxicity. Achievement of this goal does not seem possible without understanding drugs on the molecular level.
    Drug Discovery and Development - Present and Future, Edited by Izet M. Kapetanovic, 12/2011: chapter Towards Understanding Drugs on the Molecular Level to Design Drugs of Desired Profiles: pages 231-274; INTECH., ISBN: 978-953-307-615-7
  • Source

  • [Show abstract] [Hide abstract]
    ABSTRACT: We have constructed an intermolecular potential for the 1,3-dibromo-2-chloro-5-fluorobenzene molecule from first principles using SAPT(DFT) interaction energy calculations and the Williams–Stone–Misquitta method for obtaining molecular properties in distributed form. This molecule was included in the fourth Blind Test of crystal structure prediction organised by the Cambridge Crystallographic Data Centre. Using our potential, we have predicted the crystal structure of C6Br2ClFH2 and found the lowest energy solution to be in excellent agreement with the experimentally observed crystal when it was subsequently revealed.
    Chemical Physics Letters 04/2008; 456(1):105-109. DOI:10.1016/j.cplett.2008.02.113 · 1.90 Impact Factor
Show more